Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: A Leuven lung cancer group study

被引:178
作者
De Leyn, Paul
Stroobants, Sigrid
De Wever, Walter
Lerut, Toni
Coosemans, Willy
Decker, Georges
Nafteux, Philippe
Van Raefudonck, Dirk
Mortelmans, Luc
Nackaerts, Kristiaan
Vansteenkiste, Johan
机构
[1] Katholieke Univ Leuven Hosp, Dept Thorac Surg, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Nucl Med, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Pneumol, B-3000 Louvain, Belgium
关键词
D O I
10.1200/JCO.2006.05.6341
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Mediastinal restaging after induction therapy for non-small-cell lung cancer remains a difficult and controversial issue. The goal of this prospective study was to compare the performance of integrated positron emission tomography (PET) -computed tomography (CT) and remediastinoscopy in the evaluation of mediastinal lymph node metastasis after induction chemotherapy. Patients and Methods Thirty consecutive stage IIIA-N2 non-small-cell lung cancer patients surgically treated at our institution were entered onto this prospective study. N2 disease was proven by cervical mediastinoscopy, at which a mean number of 3.8 lymph node levels were biopsied. After completion of induction chemotherapy, the mediastinum was reassessed by integrated PET-CT and remediastinoscopy. All patients underwent thoracotomy with attempted complete resection and systematic nodal dissection. Results PET-CT showed no evidence of nodal disease (NO) in 13 patients, Hilar nodal disease (N1) disease in three patients, and residual mediastinal disease (N2) in 14 patients. Remediastinoscopy was positive in only five patients. The preinduction involved lymph node level could be accurately re-evaluated in 18 patients. This was not the case in the other 12 because of extensive fibrosis and adhesions. In 17 patients, persistent N2 disease was found at thoracotomy. The sensitivity, specificity, and accuracy of PET-CT were 77%, 92%, and 83%, respectively. These parameters for remediastinoscopy were 29%, 100%, and 60%, respectively. Sensitivity (P <.0001) and accuracy (P =.012) were significantly better for PET-CT. Conclusion After a thorough staging mediastinoscopy, postinduction remediastinoscopy had a disappointing sensitivity because of adhesions and fibrosis. Integrated PET-CT yielded a better result than that obtained in previous studies with side-by-side PET and CT images.
引用
收藏
页码:3333 / 3339
页数:7
相关论文
共 34 条
[1]   An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer [J].
Akhurst, T ;
Downey, RJ ;
Ginsberg, MS ;
Gonen, M ;
Bains, M ;
Korst, R ;
Ginsberg, RJ ;
Rusch, VW ;
Larson, SM .
ANNALS OF THORACIC SURGERY, 2002, 73 (01) :259-264
[2]   Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial [J].
Betticher, DC ;
Schmitz, SFH ;
Tötsch, M ;
Hansen, E ;
Joss, C ;
von Briel, C ;
Schmid, RA ;
Pless, M ;
Habicht, J ;
Roth, AD ;
Spiliopoulos, A ;
Stahel, R ;
Weder, W ;
Stupp, R ;
Egli, F ;
Furrer, M ;
Honegger, H ;
Wernli, M ;
Cerny, T ;
Ris, HB .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1752-1759
[3]   Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer [J].
Birim, Ö ;
Kappetein, AP ;
Stijnen, T ;
Bogers, AJJC .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :375-382
[4]   Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival [J].
Bueno, R ;
Richards, WG ;
Swanson, SJ ;
Jaklitsch, MT ;
Lukanich, JM ;
Mentzer, SJ ;
Sugarbaker, DJ .
ANNALS OF THORACIC SURGERY, 2000, 70 (06) :1826-1831
[5]   Positron emission tomography scanning with 2-fluoro-2-deoxy-D-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma [J].
Cerfolio, RJ ;
Ojha, B ;
Mukherjee, S ;
Pask, AH ;
Bass, CS ;
Katholi, CR .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :938-944
[6]  
De Leyn P, 2000, MINIMAL ACCESS CARDI, P169
[7]  
De Leyn Paul, 2005, Multimed Man Cardiothorac Surg, V2005, DOI 10.1510/MMCTS.2004.000166
[8]  
Detterbeck FC, 2001, DIAGNOSIS AND TREATMENT OF LUNG CANCER: AN EVIDENCE-BASED GUIDE FOR THE PRACTICING CLINICIAN, P267
[9]   Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].
Dwamena, BA ;
Sonnad, SS ;
Angobaldo, JO ;
Wahl, RL .
RADIOLOGY, 1999, 213 (02) :530-536
[10]   Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review [J].
Fischer, BMB ;
Mortensen, J ;
Hojgaard, L .
LANCET ONCOLOGY, 2001, 2 (11) :659-666